Marc Grasso
2020
In 2020, Marc Grasso earned a total compensation of $1.6M as Chief Financial Officer and Chief Business Officer at Kura Oncology, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,300 |
|---|---|
| Option Awards | $873,160 |
| Salary | $415,000 |
| Other | $43,648 |
| Total | $1,589,108 |
Grasso received $873.2K in option awards, accounting for 55% of the total pay in 2020.
Grasso also received $257.3K in non-equity incentive plan, $415K in salary and $43.6K in other compensation.
Rankings
In 2020, Marc Grasso's compensation ranked 6,586th out of 13,090 executives tracked by ExecPay. In other words, Grasso earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,586 out of 13,090 | 50th |
Division Manufacturing | 2,731 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,100 out of 2,254 | 51st |
Industry group Drugs | 954 out of 1,954 | 51st |
Industry Pharmaceutical Preparations | 713 out of 1,459 | 51st |
Pay ratio
| Marc Grasso's Pay | $1,589,108 |
|---|---|
| Median Employee's Pay | $346,674 |
| Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Marc Grasso was $1,589,108.
The annual total compensation of the median employee at Kura Oncology was $346,674.
The ratio of Marc Grasso's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 29, 2021.
Grasso's colleagues
We found five more compensation records of executives who worked with Marc Grasso at Kura Oncology in 2020.